🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Masaomi Nangaku

Bunkyo University

ORCID: 0000-0001-7401-2934

Also affiliated with University of Tokyo Hospital, The University of Tokyo

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 12 papers. Top paper: “Safety of Empagliflozin in Patients With Type 2 Diabetes and Chronic Kidney Disease: Pooled Analysis of Placebo-Controlled Clinical Trials”.

Safety of Empagliflozin in Patients With Type 2 Diabetes and Chronic Kidney Disease: Pooled Analysis of Placebo-Controlled Clinical Trials

Diabetes Care(2022)10.2337/dc21-2034
N/A
1.4DataRank · unranked
44 citations

Adeera Levin, Masaomi Nangaku, Takashi Kadowaki, Rajiv Agarwal, Sibylle J. Hauske +6 more

International consensus definitions of clinical trial outcomes for kidney failure: 2020

Kidney International(2020)10.1016/j.kint.2020.07.013
N/A
0.718DataRank · unranked
119 citations

Rajiv Agarwal, William G. Herrington, Hiddo J.L. Heerspink, Johannes F.E. Mann, Shahnaz Shahinfar +76 more

COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 diabetes using a UACR Endpoint (CONFIDENCE) trial: baseline clinical characteristics

Nephrology Dialysis Transplantation(2025)10.1093/ndt/gfaf022
N/A
0.532DataRank · unranked
22 citations

Jennifer B. Green, Hiddo J.L. Heerspink, Johannes F.E. Mann, Janet B. McGill, Amy K. Mottl +94 more

Simultaneous initiation of finerenone and empagliflozin across the spectrum of kidney risk in the CONFIDENCE trial

Nephrology Dialysis Transplantation(2025)10.1093/ndt/gfaf160
N/A
0.253DataRank · unranked
4 citations

Jennifer B. Green, Hiddo J.L. Heerspink, Sung Gyun Kim, Johannes F.E. Mann, Janet B. McGill +10 more

Design of the COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 diabetes using a UACR Endpoint study (CONFIDENCE)

Nephrology Dialysis Transplantation(2022)10.1093/ndt/gfac198
N/A
0DataRank · unranked
160 citations

Amy K. Mottl, George L. Bakris, Hiddo J.L. Heerspink, Johannes F.E. Mann, Janet B. McGill +6 more

Bone marrow stromal cell antigen-1 (CD157) regulated by sphingosine kinase 2 mediates kidney fibrosis

Frontiers in Medicine(2022)10.3389/fmed.2022.993698
N/A
0DataRank · unranked
12 citations

Yasuna Nakamura, Shinji Tanaka, Takahide Kohro, Lisa X. Li, Liping Huang +18 more

International Society of Nephrology first consensus guidance for preclinical animal studies in translational nephrology

Kidney International(2023)10.1016/j.kint.2023.03.007
N/A
0DataRank · unranked
37 citations

A. Richard Kitching, Peter Boor, Alessia Fornoni, Jürgen Floege, P. Toby Coates +63 more

Challenges and opportunities in interventions for chronic kidney disease of unknown origin (CKDu): report from the International Society of Nephrology Consortium of Collaborators on CKDu

Kidney International(2023)10.1016/j.kint.2022.10.013
N/A
0DataRank · unranked
7 citations

Jason Glaser, Jaime Butler-Dawson, Nishantha Nanayakkara, David H. Wegman, Shuchi Anand +15 more

Acquired Osteomalacia Associated with Autoantibodies against PHEX

New England Journal of Medicine(2025)10.1056/nejmc2405746
N/A
0DataRank · unranked
7 citations

Kazuo Okamoto, Tomohiro Ogawa, Hajime Katô, Koki Irie, So Watanabe +14 more

Identification of ENPP1 Haploinsufficiency in Patients With Diffuse Idiopathic Skeletal Hyperostosis and Early-Onset Osteoporosis

Journal of Bone and Mineral Research(2020)10.1002/jbmr.4550
N/A
0DataRank · unranked
43 citations

Anenya J. Ansh, Ethan R. Lester, Yuka Kinoshita, Naoko Hidaka, Yoshitomo Hoshino +13 more

Association of Serum Parathyroid Hormone Levels With All-Cause and Cause-Specific Mortality Among U.S. Adults

Endocrine Practice(2021)10.1016/j.eprac.2021.09.005
N/A
0DataRank · unranked
10 citations

Nobuaki Ito, Noriko Makita, Masaomi Nangaku, Angela M. Leung, Kosuke Inoue +1 more

Trends in the Use of Angiotensin-Converting Enzyme Inhibitor and Angiotensin-II Receptor Blocker Among United States Adults From 1999 to 2018

Endocrine Practice(2021)10.1016/j.eprac.2020.12.008
N/A
0DataRank · unranked
0 citations

Colette DeJong, Masaomi Nangaku, Kosuke Inoue